209 related articles for article (PubMed ID: 32782678)
1. Early diagnostic and prognostic value of serum exosomal miR-1246 in non-small cell lung cancer.
Huang D; Qu D
Int J Clin Exp Pathol; 2020; 13(7):1601-1607. PubMed ID: 32782678
[TBL] [Abstract][Full Text] [Related]
2. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer.
Zheng B; Peng M; Gong J; Li C; Cheng H; Li Y; Tang Y
Exp Biol Med (Maywood); 2023 Aug; 248(16):1403-1413. PubMed ID: 37551102
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
Liu W; Liu J; Zhang Q; Wei L
Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
[TBL] [Abstract][Full Text] [Related]
4. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
Zhang Y; Xu H
J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
[TBL] [Abstract][Full Text] [Related]
5. Application Value of Serum Multi-Antibody Combined Detection in Differential Diagnosis and Typing of Lung Cancer.
Cai T; Yao W; Liang F; Yang Q; Han F
J Oncol; 2022; 2022():8944263. PubMed ID: 35126518
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
Sun B; Liu HF; Ding Y; Li Z
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
[TBL] [Abstract][Full Text] [Related]
7. Reduced circulating exosomal miR-382 predicts unfavorable outcome in non-small cell lung cancer.
Luo R; Liu H; Chen J
Int J Clin Exp Pathol; 2021; 14(4):469-474. PubMed ID: 33936369
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
10. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
Han P; Zhao J; Gao L
J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
[TBL] [Abstract][Full Text] [Related]
11. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
12. Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer.
Dejima H; Iinuma H; Kanaoka R; Matsutani N; Kawamura M
Oncol Lett; 2017 Mar; 13(3):1256-1263. PubMed ID: 28454243
[TBL] [Abstract][Full Text] [Related]
13. Expression of serum exosomal miR-23b-3p in non-small cell lung cancer and its diagnostic efficacy.
Wang J; Xue H; Zhu Z; Gao J; Zhao M; Ma Z
Oncol Lett; 2020 Oct; 20(4):30. PubMed ID: 32774503
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
15. Combination of Serum miRNAs with Serum Exosomal miRNAs in Early Diagnosis for Non-Small-Cell Lung Cancer.
Wu Q; Yu L; Lin X; Zheng Q; Zhang S; Chen D; Pan X; Huang Y
Cancer Manag Res; 2020; 12():485-495. PubMed ID: 32021461
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.
Zhou GH; Yang WH; Sun B
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5696-5701. PubMed ID: 29272005
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer.
Zhang Z; Tang Y; Song X; Xie L; Zhao S; Song X
Front Oncol; 2020; 10():560025. PubMed ID: 33178588
[TBL] [Abstract][Full Text] [Related]
18. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.
Wang K; Dong L; Fang Q; Xia H; Hou X
Cancer Biomark; 2017 Sep; 20(3):283-288. PubMed ID: 28946561
[TBL] [Abstract][Full Text] [Related]
19. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
20. Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma.
Wu Y; Wei J; Zhang W; Xie M; Wang X; Xu J
Onco Targets Ther; 2020; 13():7809-7818. PubMed ID: 32801784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]